Video
What keeps you up at night in ophthalmology: Part II
Author(s):
Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.
Video Player is loading.
In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020 Glaucoma 360 meeting in San Francisco, California.
Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).
Related Videos
NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye Care
Part 1: Biggest innovations in ophthalmology in 50 years
World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbidities
AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
Related Content
